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Cascade	cyclization	and	intramolecular	nitrone	dipolar	
cycloaddition	and	formal	synthesis	of	19-hydroxyibogamine	
Ziad	T.	I.	Alkayar
a,†
	and	Iain	Coldham*
a	
A	 cascade	 or	 domino	 sequence	 of	 condensation	 of	 hydroxylamine	 and	 an	 aldehyde	 to	 give	 an	 oxime,	 cyclization	 to	 a	
nitrone,	and	intramolecular	1,3-dipolar	cycloaddition	has	been	successfully	employed	where	there	is	branching	at	C-4	as	a	
route	 to	 the	 iboga	 alkaloids.	 Cyclization	 occurs	 with	 displacement	 of	 chloride	 as	 a	 leaving	 group	 and	 intramolecular	
cycloaddition	occurs	with	an	alkene	as	a	dipolarophile.	The	reaction	gives	an	azabicyclo[2.2.2]octane	product	containing	a	
fused	 isoxazolidine	 as	 a	 single	 stereoisomer	 and	 this	 was	 converted	 to	 an	 isoquinuclidine	 that	 completed	 a	 formal	
synthesis	of	the	alkaloid	(±)-19-hydroxyibogamine.		
Introduction	
Iboga	 alkaloids	 have	 been	 isolated	 from	 plants	 of	 the	
Tabernanthe	 genus,	 found	 particularly	 in	 West	 Africa.
1
	 The	
iboga	alkaloids	are	related	by	a	common	pentacyclic	structure	
found	 in	 ibogamine	1,	 that	consists	of	an	 isoquinuclidine	core	
with	 a	 fused	 indoloazepine	 ring	 and	 representative	 examples	
are	 shown	 in	Figure	1.	Their	pharmacological	properties	have	
been	studied	widely	and	they	have	attracted	attention	due	to	
their	 ability	 to	 treat	 drug	 addiction.
2
	 Ibogaine	 2	 is	 the	 most	
abundant	of	the	alkaloids	 in	Tabernanthe	 iboga	and	has	been	
used	 clinically.	 The	 alkaloid	 catharanthine	 4	 has	 potent	
antagonist	 activity	 against	 transient	 receptor	 potential	
melastatin	8	 (TRPM8),	which	 is	 expressed	 in	 sensory	neurons	
and	involved	in	thermoregulation	and	pain.
3
	This	compound	is	
an	 important	 intermediate	 in	 the	synthesis	of	vinblastine	and	
analogues.
4
		
	 Many	 syntheses	 of	 the	 alkaloid	 ibogamine	 have	 been	
reported.
5,6
	 In	 contrast,	 there	 is	 only	 one	 report	 of	 the	
preparation	of	the	 iboga	alkaloid	(–)-19-hydroxyibogamine	5,
7
	
which	 shows	 marked	 antibiotic	 activity.
8
	 There	 is	 a	 growing	
number	of	 iboga	alkaloids	with	a	hydroxyethyl	group	or	other	
oxygenated	 side	 chain	 at	C-20	of	 the	 core	 ring	 system.
9
	Here	
we	 report	 an	 efficient	 synthesis	 of	 the	 isoquinuclidine	 core	
with	 a	 hydroxyethyl	 side	 chain	 that	 makes	 use	 of	 a	 nitrone	
cycloaddition	 as	 part	 of	 a	 cascade	 process	 involving	 simple	
condensation	of	hydroxylamine	with	an	aldehyde	followed	by	
cyclization	 on	 to	 an	 alkyl	 halide	 and	 cycloaddition.	 We	 have	
applied	this	to	a	formal	synthesis	of	19-hydroxyibogamine	5.	
	 We	have	reported	a	number	of	examples	of	the	formation	
of	 polycyclic	 amines	 by	 use	 of	 a	 cascade	 strategy	 that	
incorporates	 a	 condensation	 reaction	 of	 an	 amine	 and	 an	
aldehyde	 (or	 ketone)	 followed	 by	 in	 situ	 cyclization	 of	 the	
imine	 (or	oxime	or	hydrazone)	on	to	an	alkyl	halide,	 followed	
by	 in	 situ	 dipolar	 cycloaddition.
10–15
	 Our	 efforts	 have	 been	
centred	 mostly	 on	 fused	 ring	 systems	 (Scheme	 1a)	 and	 this	
chemistry	 leads	 to	 the	 synthesis	 of	 several	 natural	 products	
(aspidosperma	alkaloids,	myrioxazine	A).
10-11
	An	intermolecular	
cycloaddition	 alternatively	 leads	 to	 bicyclic	 products	 and	 has	
been	used	to	prepare	crispine	A	and	macronecine.
12
	We	have	
extended	 the	 methodology	 to	 bridged	 polycyclic	 compounds	
(Scheme	1b),
13
	and	recently	to	spirocyclic	compounds	(Scheme	
1c).
14
	 The	 research	 on	 the	 bridged	 compounds	 located	 the	
branch	point	 (between	 the	alkene	dipolarophile	and	 the	alkyl	
halide)	β-	to	the	aldehyde.	This	led	to	compounds	with	a	one-
carbon	 bridge.	 We	 were	 interested	 to	 see	 if	 the	 chemistry	
could	 be	 extended	 to	 compounds	 that	 would	 give	 a	 two-
carbon	 bridge	 and	 hence	 access	 the	 isoquinuclidine	 ring	
system.	Here	we	report	the	results	of	this	study	in	the	context	
of	the	synthesis	of	the	iboga	alkaloids.	
	
Figure	1	 Representative	iboga	alkaloids,	1–5.	
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Scheme	1		 Cascade	chemistry	to	polycyclic	amines	(X	=	Br,	Cl;	Y	=	O,	NR,	CHR).
10–14
	
Results	and	discussion	
	 To	 explore	 the	 ability	 to	 conduct	 the	 cascade	 chemistry	
towards	 a	 two-carbon	 bridged	 compound	 that	 could	 lead	 to	
the	iboga	alkaloids,	we	needed	to	prepare	an	aldehyde	such	as	
compound	7	with	branching	between	the	alkene	and	the	alkyl	
halide	 g-	 to	 the	 aldehyde	 (Scheme	 2).	 We	 anticipated	 that	
condensation	 of	 hydroxylamine	 with	 this	 aldehyde	 would	
provide	an	intermediate	oxime	that	would	undergo	cyclization	
with	displacement	of	the	chloride	and	subsequent	1,3-dipolar	
cycloaddition	of	the	resulting	nitrone	with	the	tethered	alkene	
to	give	the	isoquinuclidine	core	6.	
	 To	test	the	chemistry	and	to	access	the	required	aldehyde	
rapidly,	we	prepared	the	racemic	iodide	11	by	reduction	of	the	
known	 diester	 8
16
	 followed	 by	 two	 separate	 mono-
halogenations	 (Scheme	 3).	 The	 diester	 8	 was	 formed	 by	
allylation	 with	 crotyl	 bromide	 as	 a	 mixture	 of	 stereoisomers	
E:Z	5.5:1	and	could	be	reduced	without	purification.	Treatment	
of	iodide	11	with	the	anion	formed	from	(EtO)2CHCN	and	LDA	
or	 NaH	 failed	 to	 give	 any	 alkylated	 product.
17
	 We	 therefore	
turned	to	a	dithiane	anion.	Deprotonation	of	dithiane	12	with	
n-BuLi	 followed	by	addition	of	 the	 iodide	11	gave	the	desired	
alkylated	 product	 13.	 As	 expected,	 this	 occurred	 by	
displacement	 of	 the	 iodide	 not	 the	 chloride	 and	 best	
conditions	 involved	 addition	 of	 the	 iodide	 11	 at	 –40	 °C	
followed	by	warming	to	room	temperature.	
	
Scheme	2		 Retrosynthesis	for	19-hydroxyibogamine	5.	
	
Scheme	3		 Synthesis	of	the	dithiane	13.	Ratio	E:Z	5.5:1	for	8–11,	13.	
	
Scheme	4	 Synthesis	of	the	aldehydes	15	and	16.	Ratio	E:Z	5.5:1	for	13–16.	
	 The	ester	13	was	reduced	with	LiAlH4	to	give	the	alcohol	14	
(Scheme	4).	 The	presence	of	a	dimethyl	 acetal	 (rather	 than	a	
dithiane)	 adjacent	 to	 the	 required	 aldehyde	 has	 previously	
been	 found	 to	 be	 beneficial	 in	 an	 intramolecular	 dipolar	
cycloaddition	 reaction.
18
	 Therefore,	 initially,	 alcohol	 14	 was	
treated	with	methanol,	 silver	 nitrate	 and	N-chlorosuccinimde	
to	 promote	 transacetalation	 from	 the	 dithiane	 to	 the	
corresponding	 dimethyl	 acetal,	 although	 this	 new	 acetal	
proved	 to	 be	 unstable	 to	 subsequent	 Swern	 oxidation.	
Therefore,	 alcohol	 14	 was	 oxidised	 to	 give	 aldehyde	 15.	 The	
aldehyde	15	could	be	converted	to	the	dimethyl	acetal	16.	
	 We	 now	 had	 in-hand	 two	 aldehydes	 to	 test	 the	 cascade	
chemistry.	 Taking	 the	 aldehyde	 16	 (which	 was	 still	 an	
inseparable	 mixture	 of	 E:Z	 stereoisomers	 in	 a	 ratio	 of	 5.5:1)	
and	 heating	 with	 hydroxylamine	 at	 60	 °C	 gave	 the	 expected	
oxime	 17	 (Scheme	 5).	 This	 oxime	 could	 be	 isolated	 or,	
alternatively,	 directly	 raising	 the	 temperature	 to	 heat	 under	
reflux	 gave	 a	 low	 yield	 (15%)	 of	 a	 single	 stereoisomer	 of	 the	
cycloadduct	 18.	 No	 other	 isolable	 compounds	 could	 be	
obtained	and	it	appeared	that	decomposition	was	taking	place	
predominantly.	Heating	the	purified	oxime	17	in	toluene	in	the	
presence	of	
i
Pr2NEt	gave	the	same	result,	with	cycloadduct	18	
being	 isolated	 in	 only	 15%	 yield.	 Carrying	 out	 this	 cascade	
reaction	in	the	presence	of	Bu4NI	or	by	using	xylene	instead	of	
toluene	 failed	 to	 provide	 any	 cycloadduct	 18.	 The	
stereochemistry	 of	 the	 cycloadduct	 18	 was	 assigned	 on	 the	
basis	of	 similar	 coupling	 constants	 in	 its	
1
H	NMR	spectrum	 in	
comparison	with	 the	 cycloadduct	20	 (and	on	 the	basis	of	 the	
single	crystal	X-ray	analysis	of	ketone	21,	see	below).	
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Scheme	5		 Cycloaddition	from	the	aldehyde	16	to	give	(±)-18.	
	
Scheme	6		 Cycloaddition	from	the	aldehyde	15	to	give	(±)-20.	
	 With	 the	 disappointing	 result	 in	 the	 formation	 of	 the	
cycloadduct	 18,	 our	 attention	 turned	 to	 the	 corresponding	
dithiane	15.	Heating	aldehyde	15	with	the	hydrochloride	salt	of	
hydroxylamine	 in	 toluene	 and	
i
Pr2NEt	 resulted	 in	 a	 low	 yield	
(18%)	of	 the	cycloadduct	20	 (Scheme	6).	Addition	of	Bu4NI	or	
heating	 in	 xylene	 did	 not	 change	 the	 outcome	 significantly	
(22%	of	20	isolated).	However,	addition	of	MgSO4	did	improve	
the	yield,	particularly	if	the	oxime	was	allowed	to	form	at	60	°C	
prior	to	heating	at	110	°C.	In	this	case	the	cycloadduct	20	was	
isolated	 in	 36%	 yield.	 The	 difficulty	 appeared	 to	 be	 the	 poor	
formation	 of	 the	 oxime	 intermediate	 (19).	 Therefore	 an	
alternative	 strategy	was	adopted,	whereby	 the	oxime	19	was	
formed	(in	quantitative	yield)	under	modified	conditions	(with	
sodium	acetate	as	the	base	in	methanol).	The	oxime	was	then	
heated	in	toluene	with	
i
Pr2NEt	and	MgSO4	 to	give	the	desired	
cycloadduct	20	in	more	acceptable	yield	(57%).	In	the	absence	
of	 either	
i
Pr2NEt	 or	 MgSO4,	 the	 yields	 were	 lower.	 A	 single	
stereoisomer	 of	 the	 cycloadduct	 20	 was	 formed;	 the	
stereochemistry	 was	 confirmed	 as	 discussed	 below	 and	 this	
fits	with	a	concerted	cycloaddition	across	the	E-alkene.	
	 With	 a	 successful	 synthesis	 of	 the	 cycloadduct	 20,	 we	
sought	to	carry	out	further	transformations	towards	the	iboga	
alkaloid	 structures.	 Attempts	 to	 reduce	 the	N–O	 bond	 in	 the	
cycloadduct	 20	 with	 zinc	 in	 aqueous	 acetic	 acid	 gave	 only	
recovered	 starting	 material.	 Alternatively,	 hydrolysis	 of	 the	
dithiane	 was	 carried	 out	 and	 we	 found	 that	
[bis(trifluoroacetoxy)iodo]benzene	 in	 aqueous	 acetonitrile	
resulted	 in	 the	 desired	 ketone	 21	 (Scheme	 7).	 The	 relative	
stereochemistry	 of	 the	 ketone	 21	 was	 confirmed	 by	 single	
crystal	 X-ray	 analysis	 (see	 SI).	 At	 this	 point	 it	was	 possible	 to	
reduce	 the	 N–O	 bond	 with	 activated	 zinc	 in	 acetic	 acid	 and	
methanol	 to	 give	 the	 isoquinuclidine	 22.	 The	 crude	 material	
was	 coupled	 with	 3-indoleacetic	 acid	 to	 give	 the	
isoquinuclidine	 23	 in	 quantitative	 yield	 from	 the	
isoquinuclidine	 21.	 Finally,	 we	 were	 able	 to	 convert	 in	 high	
yield	 the	 ketone	 functional	 group	 to	 the	 dimethyl	 acetal	 24	
and	 the	 alcohol	 to	 the	 acetate	 so	 as	 to	 prepare	 racemic	
isoquinuclidine	 25.	 The	 NMR	 spectroscopic	 data	 of	 the	
isoquinuclidine	 25	 matched	 those	 reported	 by	 Höck	 and	
Borschberg.
7b
	 Therefore	 this	 chemistry	 provides	 a	 formal	
synthesis	of	the	alkaloid	19-hydroxyibogamine	5.	
	
Scheme	7		 Completion	 of	 the	 formal	 synthesis	 of	 19-hydroxyibogamine	 5	 by	
preparation	of	(±)-25.	
Experimental	
Reactions	 were	 carried	 out	 under	 nitrogen	 or	 argon	 using	
oven-dried	 glassware.	 Petrol	 refers	 to	 petroleum	 ether	 (b.p.	
40–60	 °C).	 Thin	 layer	 chromatography	 was	 carried	 out	 using	
silica	 plates,	 visualising	 by	 UV	 irradiation	 at	 254	 nm	 or	 by	
staining	 with	 an	 alkaline	 aqueous	 KMnO4	 dip.	 The	 silica	 gel	
used	for	column	chromatography	was	40–63	micron	mesh.	The	
chemical	 shifts	 in	 the	
1
H	 NMR	 spectra	 are	 reported	 in	 ppm	
with	 respect	 to	 residual	 solvent	 peaks,	with	multiplicities	 s	 =	
singlet,	d	=	doublet,	t	=	triplet,	q	=	quartet,	m	=	multiplet,	and	
br	=	broad.	Coupling	constants,	J,	are	quoted	to	the	nearest	0.5	
Hz.	High	resolution	(accurate	mass)	mass	spectra	(HRMS)	used	
electrospray	 ionisation	 (ESI)	 with	 a	 time-of-flight	 (TOF)	 mass	
analyzer.	
	
2-[But-2-en-1-yl]propane-1,3-diol	 9.	 Diethyl	malonate	 (24.0	 g,	
100	mmol)	was	added	to	sodium	hydride	(1.44	g,	60	mmol)	in	
THF	 (40	 mL)	 at	 room	 temperature.	 After	 15	 min,	 the	
suspension	was	added	dropwise	to	crotyl	bromide	(6.69	g,	50	
mmol,	E:Z	5.5:1)	in	THF	(100	mL).	After	3	h,	saturated	aqueous	
ammonium	chloride	 (100	mL)	and	H2O	(100	mL)	were	added.	
The	aqueous	layer	was	extracted	with	Et2O	(3	×	75	mL)	and	the	
combined	organic	extracts	were	dried	(MgSO4)	and	the	solvent	
was	evaporated.	The	crude	product	was	added	dropwise	to	a	
suspension	of	Et2O	(50	mL)	and	LiAlH4	 (3.7	g,	100	mmol)	at	0	
°C.	 After	 10	 min,	 the	 mixture	 was	 warmed	 to	 room	
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temperature.	After	3	h,	 aqueous	 sodium	hydroxide	 (25	mL,	1	
M)	 was	 added	 until	 a	 white	 precipitate	 was	 observed.	 The	
mixture	 was	 filtered	 through	 Celite
®
,	 washed	 with	
CH2Cl2−MeOH	(9:1)	(200	mL)	and	the	solvent	was	evaporated.	
Purification	 by	 column	 chromatography	 on	 silica	 gel,	 eluting	
with	petrol−EtOAc	(3:2),	gave	the	diol	9	(5.2	g,	80%)	as	an	oil	as	
a	 5.5:1	 E:Z	 mixture;	 Rf	 0.2	 [petrol−EtOAc	 (1:1)];	 IR	
νmax(film)/cm
–1	
3315,	 2915,	 2885;	
1
H	 NMR	 (400	 MHz,	 CDCl3,	
peaks	for	the	major	E	isomer)	δ	=	5.57−5.37	(2H,	m),	3.80	(2H,	
dd,	J	10.5,	4	Hz),	3.66	(2H,	dd,	J	10.5,	7.5	Hz),	2.55	(2H,	br	s),	
1.98	(2H,	t,	J	7	Hz),	1.87−1.79	(1H,	m,	CH),	1.67	(3H,	dd,	J	6,	1	
Hz);	
13
C	NMR	(101	MHz,	CDCl3,	peaks	for	the	major	E	isomer)	δ	
=	128.5,	127.2,	65.8,	42.2,	31.2,	17.9;	HRMS	(ESI-TOF)	m/z:	[M	
+	H]
+
	Calcd	for	C7H15O2	131.1070;	Found:	131.1072.	
	
2-(Chloromethyl)hex-4-en-1-ol	10.	Triphenylphosphine	(7.25	g,	
27.6	mmol)	was	added	to	the	diol	9	(3.0	g,	23	mmol)	in	CH2Cl2	
(230	mL)	at	0	 °C.	After	10	min,	 trichloroacetonitrile	 (2.31	mL,	
23.0	mmol)	was	added	dropwise	and	the	mixture	was	allowed	
to	 warm	 to	 room	 temperature.	 After	 4	 h,	 the	 solvent	 was	
evaporated.	 Purification	 by	 column	 chromatography	 on	 silica	
gel,	eluting	with	petrol–EtOAc	(4:1),	gave	the	chloroalcohol	10	
(2.89	g,	85%)	as	an	oil	as	a	5.5:1	E:Z	mixture;	Rf	0.27	 [petrol–
EtOAc	 (4:1)];	 IR	 νmax(film)/cm
–1
	 3330,	 2935,	 2915,	 1435,	 725;	
1
H	NMR	(400	MHz,	 CDCl3,	 peaks	 for	 the	major	 E	 isomer)	 δ	 =	
5.57−5.50	 (1H,	 m),	 5.43−5.35	 (1H,	 m),	 3.72−3.68	 (2H,	 m),	
3.67−3.60	(2H,	m),	2.13–2.08	(2H,	m),	1.97−1.90	(1H,	m),	1.68	
(3H,	 dd,	J	6,	 1	 Hz);	
13
C	 NMR	(101	 MHz,	 CDCl3,	 peaks	 for	 the	
major	E	 isomer)	δ	=	128.0,	127.7,	62.8,	45.6,	42.8,	31.8,	18.0;	
HRMS	 (ESI-TOF)	m/z:	 [M	+	H]
+
	 Calcd	 for	 C7H14
35
ClO	148.0655;	
Found:	148.0655;	LRMS	m/z	(ES)	150	(60%),	148	(100).	
	
6-Chloro-5-(iodomethyl)hex-2-ene	 11.	 Imidazole	 (1.64	 g,	 25.9	
mmol)	 and	 triphenylphosphine	 (6.80	 g,	 25.9	 mmol)	 were	
added	to	2-(chloromethyl)hex-4-en-1-ol	10	(3.20	g,	21.6	mmol)	
in	 THF	 (75	 mL)	 at	 room	 temperature.	 After	 15	 min,	 ground	
iodine	 (6.00	g,	23.8	mmol)	was	added	portionwise.	After	3	h,	
CH2Cl2	(50	mL)	was	added,	the	suspension	was	filtered	through	
Celite
®
	and	the	solvent	was	evaporated.	Purification	by	column	
chromatography	 on	 silica	 gel,	 eluting	 with	 petrol,	 gave	 the	
iodide	11	 (4.62	g,	83%)	as	an	oil	as	a	5.5:1	E:Z	mixture;	Rf	0.5	
(petrol);	 IR	 νmax(film)/cm
–1
	 2960,	 1435;
	 1
H	 NMR	 (400	 MHz,	
CDCl3,	 peaks	 for	 the	major	 E	 isomer)	 δ	 =	 5.62−5.54	 (1H,	m),	
5.38−5.29	 (1H,	 m),	 3.66	 (1H,	 dd,	J	11,	 4.5	 Hz),	 3.52	 (1H,	
dd,	J	11,	6.5	Hz),	3.40	(1H,	dd,	J	10,	4.5	Hz),	3.30	(1H,	dd,	J	10,	6	
Hz),	 2.16−2.06	 (2H,	m),	1.80–1.72	 (1H,	m),	 1.69	 (3H,	dd,	J	 6.5,	
1.5	 Hz);	
13
C	 NMR	 (101	 MHz,	 CDCl3,	 peaks	 for	 the	 major	 E	
isomer)	 δ	 =	 128.9,	 126.7,	 47.9,	 41.8,	 35.1,	 18.0,	 10.5;	 HRMS	
(ESI-TOF)	 m/z:	 [M]
+
	 Calcd	 for	 C7H12
35
ClI	 257.9672;	 Found:	
257.9669;	LRMS	m/z	(EI)	260	(2%),	258	(6),	55	(100).	
	
Ethyl	 2-[2-(Chloromethyl)hex-4-en-1-yl]-1,3-dithiane-2-
carboxylate	13.	n-BuLi	 (6.2	mL,	15.6	mmol,	2.5	M	 in	hexanes)	
was	 added	 to	 ethyl	 1,3-dithiane-2-carboxylate	12	 (2.0	mL,	 13	
mmol)	 in	 THF	 (35	mL)	 at	 –78	 °C.	 After	 15	min,	 the	 iodide	11	
(4.0	g,	15.6	mmol)	in	THF	(5	mL)	was	added	at	–40	°C	and	the	
mixture	was	allowed	to	warm	to	 room	temperature.	After	16	
h,	 H2O	 (40	 mL)	 was	 added	 and	 the	 aqueous	 layer	 was	
extracted	 with	 Et2O	 (3	 ×	 50	 mL),	 dried	 (MgSO4),	 and	 the	
solvent	 was	 evaporated.	 Purification	 by	 column	
chromatography	on	silica	gel,	eluting	with	petrol–EtOAc	(98:2),	
gave	the	ester	13	(3.2	g,	75%)	as	an	oil	as	a	5.5:1	E:Z	mixture;	
Rf	 0.3	 [petrol–EtOAc	 (98:2)];	 IR	 νmax(film)/cm
–1	
2980,	 2920,	
1720;	
1
H	NMR	(400	MHz,	CDCl3,	peaks	for	the	major	E	isomer)	
δ	=	5.60−5.51	 (1H,	m),	 5.40−5.32	 (1H,	m),	 4.31–4.24	 (2H,	m),	
3.68–3.61	(2H,	m),	3.33–3.25	(2H,	m),	2.73–2.67	(2H,	m),	2.27–
2.11	(5H,	m),	2.05	(1H,	dd,	J	14,	4	Hz),	1.93−1.82	(1H,	m),	1.68	
(3H,	 dd,	 J	 6,	 1	 Hz),	 1.36	 (3H,	 t,	 J	 7	 Hz);	
13
C	 NMR	 (101	MHz,	
CDCl3,	peaks	 for	 the	major	E	 isomer)	δ	=	171.0,	128.4,	127.5,	
62.1,	52.9,	49.1,	39.8,	36.8,	35.9,	27.95,	27.9,	24.4,	18.0,	14.2;	
HRMS	 (ESI-TOF)	 m/z:	 [M	 +	 H]
+
	 Calcd	 for	 C14H24O2S2
35
Cl	
323.0906;	 Found:	 323.0909;	 LRMS	 m/z	 (ES)	 325	 (45%),	 323	
(100).	
	
2-[2-(Chloromethyl)hex-4-en-1-yl]-1,3-dithian-2-ylmethanol	 14.	
The	ester	13	(3.17	g,	9.8	mmol)	in	Et2O	(5	mL)	was	added	to	a	
suspension	 of	 LiAlH4	 (0.56	 g,	 14.7	 mmol)	 in	 Et2O	 (25	 mL)	 at	
room	 temperature.	 After	 2.5	 h,	 aqueous	NaOH	 (30	mL,	 1	M)	
was	added	until	a	white	precipitate	was	observed.	The	mixture	
was	 filtered	 through	Celite
®
	washing	with	CH2Cl2−MeOH	 (9:1)	
(100	 mL)	 and	 the	 solvent	 was	 evaporated.	 Purification	 by	
column	 chromatography	 on	 silica	 gel,	 eluting	 with	
petrol−EtOAc	(4:1),	gave	the	alcohol	14	(2.2	g,	80%)	as	an	oil	as	
a	 5.5:1	 E:Z	 mixture;	 Rf	 0.5	 [petrol–EtOAc	 (4:1)];	 IR	
νmax(film)/cm
–1	
3275,	 2935,	 2910;	
1
H	 NMR	 (400	 MHz,	 CDCl3,	
peaks	for	the	major	E	isomer)	δ	=	5.59−5.50	(1H,	m),	5.42−5.34	
(1H,	m),	3.77−3.74	(2H,	m),	3.72–3.66	(2H,	m),	2.99–2.90	(2H,	
m),	 2.64–2.59	 (2H,	m),	 2.28–2.19	 (3H,	m),	 2.15–2.06	 (2H,	m),	
1.93–1.78	(2H,	m),	1.73	(1H,	dd,	14,	3	Hz),	1.68	(3H,	dd,	J	6,	1	
Hz);	
13
C	NMR	(101	MHz,	CDCl3,	peaks	for	the	major	E	isomer)	δ	
=	 128.3,	 127.7,	 64.0,	 54.8,	 49.6,	 39.0,	 36.4,	 35.9,	 25.9,	 25.8,	
24.6,	 18.0;	 HRMS	 (ESI-TOF)	 m/z:	 [M	 +	 H]
+
	 Calcd	 for	
C12H22OS2
35
Cl	281.0801;	 Found:	281.0796;	 LRMS	m/z	 (ES)	283	
(3%),	281	(8),	265	(45),	263	(100).	
	
2-[2-(Chloromethyl)hex-4-en-1-yl]-1,3-dithiane-2-carbaldehyde	
15.	 DMSO	 (0.80	 mL,	 11	 mmol)	 in	 CH2Cl2	 (1	 mL)	 was	 added	
dropwise	 to	oxalyl	 chloride	 (0.50	mL,	5.5	mmol)	 in	CH2Cl2	 (15	
mL)	 at	 –60	 °C.	 After	 5	 min,	 alcohol	 14	 (1.4	 g,	 5.0	 mmol)	 in	
CH2Cl2	 (1	 mL)	 was	 added	 dropwise.	 After	 10	 min,	 N,N-
diisopropylethylamine	(4.5	mL,	25	mmol)	was	added.	After	15	
min	 at	 –60	 °C	 the	 mixture	 was	 allowed	 to	 warm	 to	 room	
temperature,	then	water	(20	mL)	was	added.	The	mixture	was	
extracted	with	CH2Cl2	(3	×	30	mL),	the	combined	organic	layers	
were	washed	successively	with	aqueous	HCl	(2	×	15	mL,	1	M),	
H2O	 (15	mL),	 aqueous	Na2CO3	 (15	mL,	5%),	and	H2O	 (20	mL),	
then	 dried	 (MgSO4)	 and	 the	 solvent	 was	 evaporated.	
Purification	 by	 column	 chromatography	 on	 silica	 gel,	 eluting	
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with	petrol−EtOAc	(9:1)	gave	the	aldehyde	15	(1.15	g,	83%)	as	
an	 oil	 as	 a	 5.5:1	 E:Z	 mixture;	 Rf	 0.5	 [petrol–EtOAc	 (9:1)];	 IR	
νmax(film)/cm
–1	
2930,	 2855,	 1705;	
1
H	 NMR	 (400	 MHz,	 CDCl3,	
peaks	for	the	major	E	 isomer)	δ	=	9.03	(1H,	s),	5.57−5.50	(1H,	
m),	5.36−5.28	(1H,	m),	3.61	(1H,	dd,	J	11.5,	4	Hz),	3.56	(1H,	dd,	
J	11.5,	4	Hz),	3.17–3.10	(1H,	m),	3.01–2.93	(1H,	m),	2.65–2.58	
(2H,	m),	2.24–2.17	(1H,	m),	2.13–2.02	(4H,	m),	1.87–1.75	(2H,	
m),	1.68	(3H,	dd,	J	6,	1	Hz);	
13
C	NMR	(101	MHz,	CDCl3,	peaks	for	
the	major	E	 isomer)	δ	=	188.7,	128.9,	127.1,	57.7,	48.2,	37.0,	
35.9,	30.1,	26.8,	26.7,	24.3,	18.0;	HRMS	(ESI-TOF)	m/z:	[M	+	H]
+
	
Calcd	for	C12H20OS2
35
Cl	279.0644;	Found:	279.0646;	LRMS	m/z	
(ES)	281	(45%),	279	(100).	
	
4-(Chloromethyl)-2,2-dimethoxyoct-6-enal	 16.	
Bis(trifluoroacetoxy)iodobenzene	 (3.00	 g,	 6.85	 mmol)	 was	
added	 to	 aldehyde	 15	 (1.12	 g,	 4.04	 mmol)	 in	 anhydrous	
methanol	(5	mL)	at	room	temperature.	After	15	min,	saturated	
aqueous	 sodium	 bicarbonate	 (5	mL)	was	 added.	 The	mixture	
was	 extracted	with	 Et2O	 (3	 ×	 10	mL),	 dried	 (MgSO4)	 and	 the	
solvent	 was	 evaporated.	 Purification	 by	 column	
chromatography	 on	 silica	 gel,	 eluting	 with	 petrol–Et2O	 (9:1),	
gave	 the	 aldehyde	16	 (580	mg,	 62%)	 as	 an	 oil	 as	 a	 5.5:1	 E:Z	
mixture;	 Rf	 0.3	 [petrol–Et2O	 (9:1)];	 IR	 νmax(film)/cm
–1	
2945,	
2840,	 1750,	 1440;	
1
H	 NMR	 (400	 MHz,	 CDCl3,	 peaks	 for	 the	
major	E	isomer)	δ	=	9.46	(1H,	s),	5.56−5.47	(1H,	m),	5.34−5.25	
(1H,	m),	3.60–3.55	(2H,	m),	3.31	(3H,	s),	3.30	(3H,	s),	2.17–2.05	
(3H,	m),	1.87–1.80	(1H,	m),	1.75	(1H,	dd,	J	15,	5	Hz),	1.67	(3H,	
dd,	J	6,	1	Hz);	
13
C	NMR	(101	MHz,	CDCl3,	peaks	for	the	major	E	
isomer)	δ	=	199.5,	128.7,	127.3,	102.1,	49.9,	49.7,	48.4,	35.6,	
34.9,	 32.6,	 18.0;	 HRMS	 (ESI-TOF)	 m/z:	 [M	 +	 H]
+
	 Calcd	 for	
C11H20O3
35
Cl	 235.1101;	 Found:	 235.1097;	 LRMS	m/z	 (ES)	 237	
(35%),	235	(100).	
	
4-(Chloromethyl)-2,2-dimethoxyoct-6-enal	 oxime	17.	Aldehyde	
16	(100	mg,	0.43	mmol),	hydroxylamine	hydrochloride	(0.04	g,	
0.64	mmol),	N,N-diisopropylethylamine	 (0.18	mL,	 1.06	mmol)	
and	MgSO4	 in	 toluene	 (4	mL)	were	heated	 at	 60	 °C.	After	 30	
min,	 the	 mixture	 was	 cooled	 to	 room	 temperature	 and	 the	
solvent	 was	 evaporated.	 Purification	 by	 column	
chromatography	 on	 silica	 gel,	 eluting	 with	 CH2Cl2–MeOH	
(96:4),	gave	the	oxime	17	(96	mg,	90%)	as	an	oil	as	a	mixture	of	
E	 and	 Z	 alkene	 and	 oxime	 isomers;	 Rf	 0.3	 [CH2Cl2–MeOH	
(96:4)];	IR	νmax(film)/cm
–1	
3340,	2935,	1440;	
1
H	NMR	(400	MHz,	
CDCl3)	 δ	 =	 7.45	 (1H,	 s),	 7.31	 (1H,	 s),	 5.62−5.49	 (1H,	 m),	
5.37−5.29	(1H,	m),	3.63–3.60	(2H,	m),	3.28	(3H,	s),	3.26	(3H,	s),	
2.19–2.10	 (2H,	m),	2.08	 (1H,	dd,	 J	 15,	7.5	Hz),	1.95–1.88	 (1H,	
m),	1.75	(1H,	dd,	J	15,	5	Hz),	1.68	(3H,	dd,	J	6,	1.5	Hz);	
13
C	NMR	
(101	MHz,	CDCl3,	peaks	for	the	major	isomer)	δ	=	151.0,	128.4,	
127.6,	100.7,	49.3,	49.2,	48.6,	35.6,	35.5,	35.4,	18.0.	HRMS	and	
LRMS	could	not	be	obtained.	
	
8,8-Dimethoxy-5-methyl-4-oxa-3-azatricyclo[4.3.1.0
3,7
]decane	
18.	 The	 oxime	 17	 (E:Z	 5.5:1)	 (100	 mg,	 0.43	 mmol),	 N,N-
diisopropylethylamine	 (0.18	 mL,	 1.07	 mmol),	 hydroxylamine	
hydrochloride	 (40	 mg,	 0.64	 mmol)	 and	 MgSO4	 (50	 mg)	 in	
toluene	 (4	 mL)	 were	 heated	 under	 reflux.	 After	 16	 h,	 the	
mixture	was	cooled	to	room	temperature	and	the	solvent	was	
evaporated.	 Purification	 by	 column	 chromatography	 on	 silica	
gel,	eluting	with	CH2Cl2–MeOH	(97:3),	gave	the	cycloadduct	18	
(14	 mg,	 15%)	 as	 an	 oil	 as	 a	 single	 stereoisomer;	 Rf	 0.36	
[CH2Cl2–MeOH	 (9.7:0.3)];	 IR	νmax(film)/cm
–1	
2950,	2900,	1460;	
1
H	NMR	(400	MHz,	CDCl3)	δ	=	4.10	(1H,	q,	J	6	Hz),	3.49	(1H,	d,	J	
3.5	Hz),	3.37–3.01	(4H,	m),	3.26	(3H,	s),	2.97	(1H,	dt,	J	14.5,	3	
Hz),	2.18	 (1H,	dd,	 J	9.5,	3.5	Hz),	1.96–1.89	 (1H,	m),	1.82–1.80	
(1H,	m),	1.68–1.65	(2H,	m),	1.52	(1H,	dd,	J	13,	4	Hz),	1.21	(3H,	
d,	 J	 6	 Hz);	
13
C	 NMR	 (101	MHz,	 CDCl3)	 δ	 =	 100.0,	 85.6,	 60.6,	
60.3,	 48.7,	 47.8,	 40.6,	 39.0,	 34.1,	 22.8,	 20.9;	 HRMS	 (ESI-TOF)	
m/z:	[M	+	H]
+
	Calcd	for	C11H20NO3	214.1438;	Found:	214.1433;	
LRMS	m/z	(ES)	214	(100%),	182	(50).	
	
2-(2-(Chloromethyl)hex-4-en-1-yl)-1,3-dithiane-2-carbaldehyde	
oxime	 19.	 Hydroxylamine	 hydrochloride	 (135	 mg,	 2.0	 mmol)	
and	 sodium	 acetate	 (365	 mg,	 4.5	 mmol)	 were	 added	 to	
aldehyde	15	 (500	mg,	 1.8	mmol)	 in	 dry	methanol	 (25	mL)	 at	
room	temperature.	After	5	h,	the	solvent	was	evaporated.	The	
residue	was	washed	with	CH2Cl2	and	then	concentrated	to	give	
the	oxime	19	(527	mg,	100%)	which	was	used	without	further	
purification;	
1
H	 NMR	 (400	 MHz,	 CDCl3)	 δ	 =	 7.44	 (1H,	 s),	
5.62−5.50	(1H,	m),	5.38−5.30	(1H,	m),	3.67–3.60	(2H,	m),	3.16–
3.04	(2H,	m),	2.73–2.66	(2H,	m),	2.27–2.07	(5H,	m),	1.94–1.83	
(2H,	m),	 1.69	 (3H,	 dd,	 J	 6,	 1	 Hz);	
13
C	 NMR	 (101	MHz,	 CDCl3,	
peaks	for	the	major	isomer)	δ	=	153.2,	128.7,	127.4,	51.5,	48.9,	
41.0,	36.2,	35.9,	27.3,	27.2,	24.8,	18.0;	HRMS	(ESI-TOF)	m/z:	[M	
+	 H]
+
	 Calcd	 for	 C12H21NOS2
35
Cl	 294.0753;	 Found:	 294.0746;	
LRMS	m/z	(ES)	296	(48%),	294	(100).	
	
5'-Methyl-4'-oxa-3'-azaspiro-1,3-dithiane-2,8'-
tricyclo[4.3.1.0
3,7
]decane	 20.	 Oxime	 19	 (527	 mg,	 1.8	 mmol),	
N,N-diisopropylethylamine	 (0.32	 mL,	 1.8	 mmol)	 and	 MgSO4	
(100	mg)	in	toluene	(15	mL)	were	heated	under	reflux.	After	16	
h,	 the	 mixture	 was	 cooled	 to	 room	 temperature	 and	 the	
solvent	 was	 evaporated.	 Purification	 by	 column	
chromatography	 on	 silica	 gel,	 eluting	 with	 CH2Cl2–MeOH	
(97:3),	 gave	 the	 cycloadduct	20	 (263	mg,	 57%)	 as	 an	 oil	 as	 a	
single	 stereoisomer;	 Rf	 0.3	 [CH2Cl2–MeOH	 (97:3)];	 IR	
νmax(film)/cm
–1	
2925,	2900,	1440;	
1
H	NMR	(400	MHz,	CDCl3)	δ	=	
4.19	(1H,	q,	J	6	Hz),	3.87	(1H,	d,	J	3.5	Hz),	3.46	(1H,	dd,	J	14.5,	2	
Hz),	3.20–3.13	(1H,	m),	3.09–3.00	(2H,	m),	2.86–2.76	(2H,	m),	
2.42	(1H,	dd,	J	9.5,	3.5	Hz),	2.13–2.00	(3H,	m),	1.91–1.88	(2H,	
m),	1.79–1.77	(1H,	m),	1.55	(1H,	dd,	J	13.5,	4.5	Hz),	1.26	(3H,	d,	
J	 6	Hz);	
13
C	NMR	 (101	MHz,	CDCl3)	δ	=	86.6,	61.8,	59.4,	44.7,	
44.5,	 41.9,	 33.2,	 27.5,	 27.2,	 24.7,	 23.0,	 21.1;	 HRMS	 (ESI-TOF)	
m/z:	 [M	 +	 H]
+
	 Calcd	 for	 C12H20NOS2	 258.0986;	 Found:	
258.0994;	LRMS	m/z	(ES)	258	(100%).	
	
5-Methyl-4-oxa-3-azatricyclo[4.3.1.0
3,7
]decan-8-one	 21.	
Bis(trifluoroacetoxy)iodobenzene	 (500	 mg,	 1.16	 mmol),	 and	
trifluoroacetic	acid	 (10	equiv.)	was	added	 to	dithiane	20	 (300	
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mg,	 1.16	 mmol)	 in	 acetonitrile/water	 (1:1)	 (44	 mL)	 at	 room	
temperature.	Additional	bis(trifluoroacetoxy)iodobenzene	(1.9	
g,	4.4	mmol)	was	added	over	a	1	h	period,	and	the	mixture	was	
stirred	 for	 2.5	 h,	 before	 being	 neutralised	 with	 saturated	
aqueous	 sodium	 bicarbonate	 (30	 mL).	 The	 mixture	 was	
extracted	 with	 CH2Cl2	 (3	 ×	 10	 mL),	 dried	 (MgSO4)	 and	 the	
solvent	 was	 evaporated.	 Purification	 by	 column	
chromatography	 on	 silica	 gel,	 eluting	 with	 CH2Cl2–MeOH	
(97:3),	 gave	 the	 ketone	 21	 (155	 mg,	 80%)	 as	 needles,	 m.p.	
62−63.5	 °C;	 Rf	 0.32	 [CH2Cl2–MeOH	 (97:3)];	 IR	 νmax(film)/cm
–1	
2965,	1730,	1450;	
1
H	NMR	(400	MHz,	CDCl3)	δ	=	4.26	(1H,	q,	J	6	
Hz),	3.62	 (1H,	d,	 J	3.5	Hz),	3.51	 (1H,	dd,	 J	14.5,	2.5	Hz),	3.30–
3.20	 (1H,	 m),	 2.45	 (1H,	 dd,	 J	 9,	 3.5	 Hz),	 2.25–2.23	 (2H,	 m),	
2.20–2.18	(1H,	m),	2.03–1.96	(1H,	m),	1.79	(1H,	dd,	J	13.5,	4.5	
Hz),	1.21	(3H,	d,	J	6	Hz);	
13
C	NMR	(101	MHz,	CDCl3)	δ	=	209.1,	
85.6,	 68.9,	 61.5,	 44.8,	 44.5,	 34.1,	 23.3,	 20.5;	 HRMS	 (ESI-TOF)	
m/z:	 [M	+	H]
+
	Calcd	for	C9H14NO2	168.1019;	Found:	168.1020;	
LRMS	m/z	(ES)	168	(100%).	
	
7-[(1RS)-1-Hydroxyethyl]-2-[2-(1H-indol-3-yl)acetyl]-2-
azabicyclo[2.2.2]octan-6-one	 23.	 Activated	 Zn	 powder	 (168	
mg,	2.6	mmol)	[washed	with	freshly	prepared	aqueous	HCl	(1.0	
M),	EtOH,	then	Et2O]	was	added	to	the	cycloadduct	21	(85	mg,	
0.51	mmol)	 in	AcOH–MeOH	(5	mL,	4:1)	at	room	temperature.	
After	 4	 h,	 the	 mixture	 was	 filtered	 through	 Celite
®
	 and	 the	
solvent	was	evaporated.	The	residue	was	dissolved	in	MeOH	(5	
mL)	and	poured	onto	aqueous	sodium	hydroxide	(5	mL,	2	M).	
The	 aqueous	 layer	was	 extracted	with	 CH2Cl2	 (3	 ×	 5	mL)	 and	
the	organic	layers	were	dried	(MgSO4)	and	evaporated	to	give	
the	 crude	 aminoalcohol	22	 (86	mg,	 100%).	 Indole	 acetic	 acid	
(89	mg,	0.51	mmol)	and	EDCI	(97	mg,	0.51	mmol)	were	added	
to	 the	 crude	 amino	 alcohol	 (86	mg,	 0.51	mmol)	 in	 CH2Cl2	 (6	
mL)	 at	 room	 temperature.	 After	 1.5	 h,	 the	 mixture	 was	
extracted	 with	 CH2Cl2	 (3	 ×	 15	 mL).	 The	 organic	 layers	 were	
combined	and	were	washed	with	aqueous	HCl	(1.5	mL,	0.01	M)	
and	with	saturated	aqueous	K2CO3	(1.5	mL),	dried	(MgSO4)	and	
the	 solvent	 was	 evaporated.	 Purification	 by	 column	
chromatography	on	silica	gel,	eluting	with	CH2Cl2–MeOH	(9:1),	
gave	the	amide	23	(165	mg,	100%)	as	a	foam;	Rf	0.39	[CH2Cl2–
MeOH	(9:1)];	IR	νmax(film)/cm
–1	
3320,	
	
2970,	1730,	1625,	1460;	
1
H	NMR	(400	MHz,	CDCl3,	as	a	mixture	of	rotamers	64:36,	data	
for	major	 rotamer)	δ	=	8.50	 (1H,	br	 s),	 7.59	 (1H,	d,	 J	 7.5	Hz),	
7.38	(1H,	d,	J	7.5	Hz),	7.24−7.11	(3H,	m),	5.01	(1H,	d,	J	1.5	Hz),	
3.96–3.93	 (2H,	 m),	 3.59–3.52	 (2H,	 m),	 3.32–3.28	 (1H,	 m),	
2.49−2.33	 (3H,	 m),	 1.89–1.81	 (2H,	 m),	 1.16	 (3H,	 d,	 J	 6	 Hz),	
1.07−1.03	 (1H,	m);	
13
C	NMR	(101	MHz,	CDCl3,	as	a	mixture	of	
rotamers,	 data	 for	 major	 rotamer)	 δ	 =	 206.6,	 173.3,	 136.1,	
127.1,	 122.9,	 122.3,	 119.8,	 118.3,	 111.5,	 107.7,	 68.7,	 54.7,	
50.3,	43.7,	42.5,	30.7,	28.4,	27.7,	19.6;	HRMS	(ESI-TOF)	m/z:	[M	
+	H]
+
	 Calcd	 for	 C19H22N2O3	 327.1703;	 Found:	 327.1703;	 LRMS	
m/z	(ES)	327	(100%).	
	
7-[(1RS)-1-Hydroxyethyl]-6,6-dimethoxy-2-azabicyclo	
[2.2.2]octan-2-yl]-2-(1H-indol-3-yl)ethanone	 24.	 p-
Toluenesulfonic	acid	(7.5	mg,	0.04	mmol)	was	added	to	crude	
23	 (100	mg,	 0.31	mmol),	 trimethylorthoformate	 (1.21	mL,	 11	
mmol)	 and	MeOH	 (1.2	 mL)	 at	 room	 temperature.	 After	 7	 h,	
saturated	 aqueous	 NaHCO3	 (1.5	 mL)	 was	 added	 and	 the	
mixture	was	extracted	with	CH2Cl2	 (3	×	10	mL),	dried	(MgSO4)	
and	 the	 solvent	 was	 evaporated.	 Purification	 by	 column	
chromatography	 on	 silica	 gel,	 eluting	 with	 CH2Cl2–MeOH	
(97:3),	gave	amide	24	(98	mg,	85%)	as	a	foam;	Rf	0.35	[CH2Cl2–
MeOH	 (95:5)];	 IR	 νmax(film)/cm
–1	
3320,
	
2970,	 1625,	 1460;	
1
H	
NMR	(400	MHz,	CDCl3,	as	a	mixture	of	rotamers	~9:1,	data	for	
major	 rotamer)	 δ	 =	 8.33	 (1H,	 br	 s),	 7.61	 (1H,	 d,	 J	 8	Hz),	 7.38	
(1H,	 d,	 J	 8	 Hz),	 7.23−7.15	 (3H,	m,	 ArH),	 4.78	 (1H,	 d,	 J	 1	 Hz),	
4.17–4.10	(1H,	m),	3.83−3.80	(2H,	m),	3.53–3.49	(1H,	m),	3.36	
(1H,	 dd,	 J	 10,	 3	Hz),	 3.23	 (3H,	 s),	 3.14	 (3H,	 s),	 2.09−2.05	 (1H,	
m),	1.96–1.88	(1H,	m),	1.76–1.69	(3H,	m),	1.15	(3H,	d,	J	6	Hz),	
0.84−0.79	(1H,	m);	
13
C	NMR	(101	MHz,	CDCl3)	δ	=	172.7,	136.1,	
127.2,	 122.7,	 122.2,	 119.6,	 118.5,	 111.3,	 108.6,	 101.4,	 69.6,	
49.2,	48.6,	48.1,	47.1,	40.9,	37.2,	30.4,	28.7,	27.6,	19.6;	HRMS	
(ESI-TOF)	m/z:	[M	+	H]
+
	Calcd	for	C21H28N2O4	373.2122;	Found:	
373.2122;	LRMS	m/z	(ES)	373	(100%).	
	
2-[2-(1H-Indol-3-yl)acetyl]-7,7-dimethoxy-2-
azabicyclo[2.2.2]octan-6-yl]ethyl	 acetate	 25.
7b
	 Acetyl	 chloride	
(0.02	mL,	0.3	mmol)	and	pyridine	 (0.024	mL,	0.3	mmol)	were	
added	to	the	alcohol	24	(100	mg,	0.28	mmol)	in	CH2Cl2	(6	mL)	
at	 room	 temperature.	 After	 30	 min,	 the	 solvent	 was	
evaporated.	 Purification	 by	 column	 chromatography	 on	 silica	
gel,	eluting	with	CH2Cl2–MeOH	(97.5:2.5),	gave	the	ester	25	(98	
mg,	 87%)	 as	 a	 foam;	 Rf	 0.26	 CH2Cl2–MeOH	 (97.5:2.5)];	 IR	
νmax(film)/cm
–1	
3280,	
	
2940,	 1730,	 1640,	 1450;	
1
H	 NMR	 (400	
MHz,	 CDCl3,	 as	 a	 mixture	 of	 rotamers	 ~8:1,	 data	 for	 major	
rotamer)	δ	=	8.30	(1H,	br	s),	7.57	(1H,	dd,	J	8,	1	Hz),	7.36	(1H,	
dd,	 J	8,	1	Hz),	7.23−7.22	 (1H,	m),	7.19	 (1H,	ddd,	 J	8,	7,	1	Hz),	
7.13	(1H,	ddd,	J	8,	7,	1	Hz),	4.91	(1H,	d,	J	1.5	Hz),	4.52	(1H,	dq,	J	
10.5,	6	Hz),	3.77−3.74	(2H,	m),	3.39	(1H,	dt,	J	10,	2.5	Hz),	3.29	
(1H,	dt,	J	10,	2.5	Hz),	3.26	(3H,	s),	3.20	(3H,	s),	2.29−2.20	(1H,	
m),	2.13	(3H,	s),	2.05−2.02	(1H,	m),	1.78	(1H,	dt,	J	13.5,	2.5	Hz),	
1.74−1.69	(1H,	m),	1.66	(1H,	dt,	J	13.5,	2.5	Hz),	1.22	(3H,	d,	J	6	
Hz),	0.92	(1H,	ddt,	13.5,	5.5,	2.5	Hz);	
13
C	NMR	(101	MHz,	CDCl3,	
as	 a	mixture	of	 rotamers,	 data	 for	major	 rotamer)	δ	=	171.2,	
171.1,	 136.1,	 127.4,	 122.9,	 121.9,	 119.3,	 118.4,	 111.2,	 108.9,	
101.7,	71.4,	49.0,	48.9,	48.1,	45.8,	38.1,	36.9,	30.7,	28.2,	27.5,	
21.5,	17.8;	HRMS	(ESI-TOF)	m/z:	[M	+	H]
+
	Calcd	for	C23H31N2O5	
415.2227;	 Found:	 415.2227;	 LRMS	m/z	 (ES)	 415	 (100%).	Data	
match	the	literature.
7b
	
Conclusions	
We	 have	 demonstrated	 that	 cascade	 chemistry	 involving	
condensation	 of	 hydroxylamine	 and	 an	 aldehyde	 to	 give	 an	
oxime,	 cyclization	on	 to	an	alkyl	halide	 to	give	a	nitrone,	and	
intramolecular	dipolar	cycloaddition	is	successful	 in	which	the	
branch	point	 for	 the	alkyl	halide	and	alkene	 tethers	 is	at	C-4.	
This	 leads	 to	 bridged	 compounds	 with	 the	
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azabicyclo[2.2.2]octane	 framework	 and	 thereby	 extends	 the	
methodology	 described	previously	 (Scheme	1)	 to	 a	 new	 class	
of	ring	system.	In	addition,	the	chemistry	has	been	applied	to	a	
formal	 synthesis	 of	 the	 alkaloid	 19-hydroxyibogamine.	 The	
cascade	sequence	has	potential	 for	the	formation	of	a	variety	
of	iboga	alkaloid	frameworks.		
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